Can hyperthermic intrathoracic perfusion chemotherapy added to lung sparing surgery be the solution for malignant pleural mesothelioma?

Isik A. F., Sanli M., Dikensoy Ö., Aytekin I., Benli Y., Sevinc A., ...More

TURK GOGUS KALP DAMAR CERRAHISI DERGISI-TURKISH JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, vol.24, no.2, pp.325-332, 2016 (SCI-Expanded) identifier identifier

  • Publication Type: Article / Article
  • Volume: 24 Issue: 2
  • Publication Date: 2016
  • Doi Number: 10.5606/tgkdc.dergisi.2016.11798
  • Journal Name: TURK GOGUS KALP DAMAR CERRAHISI DERGISI-TURKISH JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
  • Page Numbers: pp.325-332
  • Keywords: Hyperthermic perfusion chemotherapy, mesothelioma, pleura, surgery, EXTRAPLEURAL PNEUMONECTOMY, INTERNATIONAL MESOTHELIOMA, PERITONEAL CARCINOMATOSIS, COMPLETE RESECTION, EXPERIENCE, MANAGEMENT, SURVIVAL, CANCER
  • Acibadem Mehmet Ali Aydinlar University Affiliated: No

Abstract

Background: This study aims to investigate whether hyperthermic intrathoracic perfusion chemotherapy added to lung sparing cytoreductive surgery is superior to extrapleural pneumonectomy in patients with malignant pleural mesothelioma in terms of survival.